Virtual Medicinal Product (VMP) - Cabotegravir 600mg/3ml prolonged-release suspension for injection vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Cabotegravir 600mg/3ml prolonged-release suspension for injection vials | Start Date 06-10-2021 | End Date |
| Abbreviated Name | Abbreviated Name Cabotegravir 600mg/3ml prolonged-release inj vials | Start Date 06-10-2021 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 3
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Prolonged-release suspension for injection
- Ontology Form/Route
- suspensioninjectionprolonged-release.intramuscular
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- J05AJ04
- BNF Codes
-
- BNF code 05030100
| Code | Start Date | End Date |
|---|---|---|
| 40163511000001103 | 06-10-2021 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Cabotegravir | Based on Ingredient Substance | 200 mg | 1 ml |
Name
Cabotegravir
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
200
Strength and UOM (Dmr)
1
Parent Products
-
VTMCabotegravir
-
VMP(Current) Cabotegravir 600mg/3ml prolonged-rel...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 vial |